kv1 5 Search Results


kv1 5  (Alomone Labs)
93
Alomone Labs kv1 5
Kv1 5, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/kv1 5/product/Alomone Labs
Average 93 stars, based on 1 article reviews
kv1 5 - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier
kcna5  (Santa Cruz Biotechnology)
93
Santa Cruz Biotechnology kcna5
Kcna5, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/kcna5/product/Santa Cruz Biotechnology
Average 93 stars, based on 1 article reviews
kcna5 - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier
swine  (Alomone Labs)
93
Alomone Labs swine
Swine, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/swine/product/Alomone Labs
Average 93 stars, based on 1 article reviews
swine - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier
kv1 5 shrna human ltv particles  (Santa Cruz Biotechnology)
85
Santa Cruz Biotechnology kv1 5 shrna human ltv particles
Kv1 5 Shrna Human Ltv Particles, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/kv1 5 shrna human ltv particles/product/Santa Cruz Biotechnology
Average 85 stars, based on 1 article reviews
kv1 5 shrna human ltv particles - by Bioz Stars, 2026-02
85/100 stars
  Buy from Supplier
kv1.5 experiments  (AstraZeneca ltd)
90
AstraZeneca ltd kv1.5 experiments
Kv1.5 Experiments, supplied by AstraZeneca ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/kv1.5 experiments/product/AstraZeneca ltd
Average 90 stars, based on 1 article reviews
kv1.5 experiments - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
kv1.5 currents  (IDrug GmbH)
90
IDrug GmbH kv1.5 currents
Kv1.5 Currents, supplied by IDrug GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/kv1.5 currents/product/IDrug GmbH
Average 90 stars, based on 1 article reviews
kv1.5 currents - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
kv1.5  (ImmunoWay Biotechnology Company)
90
ImmunoWay Biotechnology Company kv1.5
(A) Western blot bands showing p-CaMKII together with p-RyR2. (B) and (C) The relative p-CaMKII and p-RyR2 protein expression. (D) Western blot bands of <t>Kv1.5,</t> Kir3.1 and Kir3.4. (E-G) The relative levels of Kv1.5, Kir3.1 and Kir3.4 proteins; (n = 3). *P < 0.05, **P < 0.01, ***P < 0.001 versus Con group; #P < 0.05, ##P < 0.01, ###P < 0.001, versus AngII group.
Kv1.5, supplied by ImmunoWay Biotechnology Company, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/kv1.5/product/ImmunoWay Biotechnology Company
Average 90 stars, based on 1 article reviews
kv1.5 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
kv1.5-specific blocker dmm  (Cardiome Inc)
90
Cardiome Inc kv1.5-specific blocker dmm
(A) Western blot bands showing p-CaMKII together with p-RyR2. (B) and (C) The relative p-CaMKII and p-RyR2 protein expression. (D) Western blot bands of <t>Kv1.5,</t> Kir3.1 and Kir3.4. (E-G) The relative levels of Kv1.5, Kir3.1 and Kir3.4 proteins; (n = 3). *P < 0.05, **P < 0.01, ***P < 0.001 versus Con group; #P < 0.05, ##P < 0.01, ###P < 0.001, versus AngII group.
Kv1.5 Specific Blocker Dmm, supplied by Cardiome Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/kv1.5-specific blocker dmm/product/Cardiome Inc
Average 90 stars, based on 1 article reviews
kv1.5-specific blocker dmm - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
kv1.5 antibody-coated protein a beads  (Upstate Biotechnology Inc)
90
Upstate Biotechnology Inc kv1.5 antibody-coated protein a beads
(A) Western blot bands showing p-CaMKII together with p-RyR2. (B) and (C) The relative p-CaMKII and p-RyR2 protein expression. (D) Western blot bands of <t>Kv1.5,</t> Kir3.1 and Kir3.4. (E-G) The relative levels of Kv1.5, Kir3.1 and Kir3.4 proteins; (n = 3). *P < 0.05, **P < 0.01, ***P < 0.001 versus Con group; #P < 0.05, ##P < 0.01, ###P < 0.001, versus AngII group.
Kv1.5 Antibody Coated Protein A Beads, supplied by Upstate Biotechnology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/kv1.5 antibody-coated protein a beads/product/Upstate Biotechnology Inc
Average 90 stars, based on 1 article reviews
kv1.5 antibody-coated protein a beads - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


(A) Western blot bands showing p-CaMKII together with p-RyR2. (B) and (C) The relative p-CaMKII and p-RyR2 protein expression. (D) Western blot bands of Kv1.5, Kir3.1 and Kir3.4. (E-G) The relative levels of Kv1.5, Kir3.1 and Kir3.4 proteins; (n = 3). *P < 0.05, **P < 0.01, ***P < 0.001 versus Con group; #P < 0.05, ##P < 0.01, ###P < 0.001, versus AngII group.

Journal: PLOS ONE

Article Title: Hydrogen decreases susceptibility to AngII-induced atrial fibrillation and atrial fibrosis via the NOX4/ROS/NLRP3 and TGF-β1/Smad2/3 signaling pathways

doi: 10.1371/journal.pone.0310852

Figure Lengend Snippet: (A) Western blot bands showing p-CaMKII together with p-RyR2. (B) and (C) The relative p-CaMKII and p-RyR2 protein expression. (D) Western blot bands of Kv1.5, Kir3.1 and Kir3.4. (E-G) The relative levels of Kv1.5, Kir3.1 and Kir3.4 proteins; (n = 3). *P < 0.05, **P < 0.01, ***P < 0.001 versus Con group; #P < 0.05, ##P < 0.01, ###P < 0.001, versus AngII group.

Article Snippet: Thereafter, primary antibodies, which included NOX4 (14347-1-AP, Proteintech, 1:1000), p22phox (sc-271968, Santa Cruz Biotechnology, 1:200), NLRP3 (ab214185, Abcam, 1:1000), ASC (sc-514414, Santa Cruz Biotechnology, 1:200), caspase1-p20 (22915–1-AP, Santa Cruz Biotechnology, 1:1,000), phospho-CaMKII (ab182674, Abcam, 1:1000), phospho-RyR2 (Ser2814,GTX00626, Genetex, 1:1000), Kv1.5 (YT2507, ImmunoWay, 1:1000), Kir3.1 (YT2475, ImmunoWay, 1:1000), Kir3.4 (YT2475, ImmunoWay, 1:1000), TGF-β1 (ab215715, Abcam, 1:1000), phospho-TGFβR I (YP1191, ImmunoWay; 1:1000), phospho-TGFβR II (A1415, Abclonal, 1:1000), phospho-Smad2 (YP1185, ImmunoWay; 1:1000), phospho-Smad3 (YP0585, ImmunoWay; 1:1000), α-SMA (bs-10196R, Bioss, 1:1000), collagen I (bs-0578R, Bioss, 1:500), collagen III (bs-0549R,Bioss, 1:500), and GAPDH (10494-1-AP, Proteintech, 1:10000), were added for overnight membrane incubation under 4°C in the shaker.

Techniques: Western Blot, Expressing

(A) ROS production in HL-1 cells by immunofluorescence staining (×200). (B) Expression of NLRP3 within HL-1 cells by immunofluorescence staining (×200). (C) Intracellular Ca 2+ concentration in HL cells by fluorescent probes (×200). (D), (E) and (F) mRNAs of Kv1.5, Kir3.1 and Kir3.4 by qRT-PCR. (n = 3). * P < 0.05, ** P < 0.01, *** P < 0.001, versus Con group; # P < 0.05, ## P < 0.01, ### P < 0.001, versus AngII group.

Journal: PLOS ONE

Article Title: Hydrogen decreases susceptibility to AngII-induced atrial fibrillation and atrial fibrosis via the NOX4/ROS/NLRP3 and TGF-β1/Smad2/3 signaling pathways

doi: 10.1371/journal.pone.0310852

Figure Lengend Snippet: (A) ROS production in HL-1 cells by immunofluorescence staining (×200). (B) Expression of NLRP3 within HL-1 cells by immunofluorescence staining (×200). (C) Intracellular Ca 2+ concentration in HL cells by fluorescent probes (×200). (D), (E) and (F) mRNAs of Kv1.5, Kir3.1 and Kir3.4 by qRT-PCR. (n = 3). * P < 0.05, ** P < 0.01, *** P < 0.001, versus Con group; # P < 0.05, ## P < 0.01, ### P < 0.001, versus AngII group.

Article Snippet: Thereafter, primary antibodies, which included NOX4 (14347-1-AP, Proteintech, 1:1000), p22phox (sc-271968, Santa Cruz Biotechnology, 1:200), NLRP3 (ab214185, Abcam, 1:1000), ASC (sc-514414, Santa Cruz Biotechnology, 1:200), caspase1-p20 (22915–1-AP, Santa Cruz Biotechnology, 1:1,000), phospho-CaMKII (ab182674, Abcam, 1:1000), phospho-RyR2 (Ser2814,GTX00626, Genetex, 1:1000), Kv1.5 (YT2507, ImmunoWay, 1:1000), Kir3.1 (YT2475, ImmunoWay, 1:1000), Kir3.4 (YT2475, ImmunoWay, 1:1000), TGF-β1 (ab215715, Abcam, 1:1000), phospho-TGFβR I (YP1191, ImmunoWay; 1:1000), phospho-TGFβR II (A1415, Abclonal, 1:1000), phospho-Smad2 (YP1185, ImmunoWay; 1:1000), phospho-Smad3 (YP0585, ImmunoWay; 1:1000), α-SMA (bs-10196R, Bioss, 1:1000), collagen I (bs-0578R, Bioss, 1:500), collagen III (bs-0549R,Bioss, 1:500), and GAPDH (10494-1-AP, Proteintech, 1:10000), were added for overnight membrane incubation under 4°C in the shaker.

Techniques: Immunofluorescence, Staining, Expressing, Concentration Assay, Quantitative RT-PCR